Pharmacy

Your Article Summary

See Latest Articles

Cost-Utility Analysis of Varenicline, an Oral Smoking-Cessation Drug, in Japan.
PharmacoEconomics, 04/16/09

Igarashi A et al. - As with any data of this nature, there is some uncertainty in the results and further research is warranted. However, based on the results of this pharmacoeconomic evaluation, varenicline, the first non-nicotine, oral treatment developed for smoking cessation, appears to be cost effective and may contribute to future medical cost savings in Japan.

Today in Neuro/Psych pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09

Chronic treatment with Escitalopram, but not R-citalopram translocates G?s from lipid raft domains and potentiates adenylyl cyclase: A 5-HT transporter independent action of this antidepressant compound
Journal of Pharmacology and Experimental Therapeutics, 12/09/09

Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes
Pharmacoepidemiology and Drug Safety, 12/09/09

 See all of Neuro/Psych pharmacology

Today in Pharmacoeconomics...keeping you current

Receive free subspecialty "5-minute updates" via email

The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/08/09

Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
American Journal of Health-System Pharmacy, 12/08/09

Costs and benefits of dropout schedules of test-restudy practice: Implications for student learning
Applied Cognitive Psychology, 12/07/09

 See all of Pharmacoeconomics